Specialty· July 11, 2026 · 16 min read
Hemophilia Access 2026: Prophylaxis and Gene Therapy Post-Roctavian
By Ran Chen#Gene Therapy#Hematology#Payer Coverage
Topic
Gene Therapy
Gene therapy approvals, outcomes evidence, site readiness, payer contracts, and one-time treatment access.
Pricing & Access· June 28, 2026 · 21 min read
Casgevy Access Guide: CMS CGT Model, State Medicaid Criteria, and the ATC Network
By Ran Chen#Medicaid#Prior Authorization#Gene Therapy
Pricing & Access· June 10, 2026 · 9 min read
CAR-T cell therapy access landscape: seven products in 2026
By Ran Chen#CAR-T#Oncology#Prior Authorization
Manufacturing· June 9, 2026 · 6 min read
The commercial ecosystem behind cell & gene therapy: ASGCT 2026 exhibitors mapped
Deals· June 9, 2026 · 6 min read
Biotech's two big shows compared: BIO 2026 vs ASGCT 2026
Pricing & Access· May 27, 2026 · 12 min read
Yescarta vs Tecartus CAR-T access guide
By Ran Chen#Oncology#CAR-T#Prior Authorization